Actively Recruiting
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Led by Skingenix, Inc. · Updated on 2026-03-16
60
Participants Needed
6
Research Sites
250 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
CONDITIONS
Official Title
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults, 18 years of age or older on the day of signing the informed consent
- Thermal burns not exceeding a total body surface area (TBSA) of 25%, with at least one partial thickness burn of 0.5% TBSA or greater
- If full thickness burns are present at screening, the total full thickness burn area must not exceed 10% TBSA
- Able and willing to give informed consent and comply with study procedures
You will not qualify if you...
- Any burn that is infected at screening
- Any circumferential burn or burn deemed at high risk for developing compartment syndrome
- Partial thickness burns likely to require grafting within 72 hours or other non-protocol intervention
- Severe inhalation injury or other significant non-burn trauma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Valleywise Health Medical Center
Phoenix, Arizona, United States, 85008
Actively Recruiting
2
University of CA Davis Medical Center
Sacramento, California, United States, 95817
Actively Recruiting
3
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
4
University of Iowa Health Care
Iowa City, Iowa, United States, 52242
Actively Recruiting
5
Proactive CR Mexico SA de CV
Irapuato, Mexico
Actively Recruiting
6
SMIQ S de R. L de CV
Querétaro City, Mexico
Actively Recruiting
Research Team
V
Vicki Christodoulou, MS, JD
CONTACT
E
Eric Wang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here